Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for Tivic Health Systems (TIVC) over the last 5 years, with Q3 2025 value amounting to -$327000.0.

  • Tivic Health Systems' Change in Accured Expenses fell 49878.05% to -$327000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$54000.0, marking a year-over-year decrease of 38421.05%. This contributed to the annual value of -$348000.0 for FY2024, which is 43786.41% down from last year.
  • Latest data reveals that Tivic Health Systems reported Change in Accured Expenses of -$327000.0 as of Q3 2025, which was down 49878.05% from $197000.0 recorded in Q2 2025.
  • In the past 5 years, Tivic Health Systems' Change in Accured Expenses registered a high of $287000.0 during Q4 2023, and its lowest value of -$327000.0 during Q3 2025.
  • Over the past 5 years, Tivic Health Systems' median Change in Accured Expenses value was -$10000.0 (recorded in 2021), while the average stood at $947.37.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 39487.18% in 2022, then crashed by 143000.0% in 2023.
  • Tivic Health Systems' Change in Accured Expenses (Quarter) stood at -$39000.0 in 2021, then soared by 394.87% to $115000.0 in 2022, then skyrocketed by 149.57% to $287000.0 in 2023, then plummeted by 127.87% to -$80000.0 in 2024, then tumbled by 308.75% to -$327000.0 in 2025.
  • Its Change in Accured Expenses was -$327000.0 in Q3 2025, compared to $197000.0 in Q2 2025 and $156000.0 in Q1 2025.